Literature DB >> 7440630

Increasing human serum ribonuclease activity is a concomitant phenomenon of ovarian carcinoma.

H G Schleich, W Wiest.   

Abstract

The levels of total human serum RNAase activity (HSRA) from 24 patients with ovarian cancer have been followed up for a period of over 5 months. The determinations of HSRA were carried out according to our assay system described earlier. Two representative patterns of the HSRA are presented, one from a patient with an ascertained remission of an ovarian carcinoma. Increasing HSRA values are concomitant with tumor progression while in remission the HSRA remains at normal rates. We have reported earlier that optimum HSRA depends on physiological concentrations of NaCl in the reaction mixture. However, NaCl can be replaced by KCl without a loss of activity. No correlation was detectable between increased HSRA and an excessive electrolyte content in serum. The mixtures of sera with various RNAase activities showed linear additivity. These findings suggest that an increased concentration of the RNAases normally present in human serum and/or additional RNAases are responsible for the increase of the HSRA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7440630     DOI: 10.1007/bf00405783

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  18 in total

1.  Blood nucleases and infectious viral nucleic acids.

Authors:  R M HERRIOTT; J H CONNOLLY; S GUPTA
Journal:  Nature       Date:  1961-03-11       Impact factor: 49.962

2.  Effect of disease states on the ribonuclease concentration of body fluids.

Authors:  A L LEVY; A ROTTINO
Journal:  Clin Chem       Date:  1960-02       Impact factor: 8.327

3.  Serum Ribonuclease in Patients with Malignant Disease.

Authors:  J Zytko; A Cantero
Journal:  Can Med Assoc J       Date:  1962-03-17       Impact factor: 8.262

4.  The effects of polyamines on a residue-specific human plasma ribonuclease.

Authors:  M Schmukler; P B Jewett; C C Levy
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

5.  Purification and properties of alkaline ribonuclease from human serum.

Authors:  K Akagi; K Murai; N Hirao; M Yamanaka
Journal:  Biochim Biophys Acta       Date:  1976-09-06

6.  Levels of serum ribonuclease as an indicator of renal insufficiency in patients with leukemia.

Authors:  R L Humphrey; T P Karpetsky; E A Neuwelt; C C Levy
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

7.  Purification and properties of acid ribonucleases in human serum and leukocytes.

Authors:  K Akagi; M Yamanaka; K Murai; T Omae
Journal:  Cancer Res       Date:  1978-07       Impact factor: 12.701

8.  Abnormal profile of human nucleolytic activity as a test for cancer.

Authors:  W P Drake; M Schmukler; W J Pendergrast; A S Davis; J L Lichtenfeld; M R Mardiney
Journal:  J Natl Cancer Inst       Date:  1975-11       Impact factor: 13.506

9.  Serum ribonucleases in cancer: relation to tumor histology.

Authors:  P B Chretien; W Matthews; P L Twomey
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

10.  Elevated serum ribonuclease in patients with pancreatic cancer.

Authors:  K K Reddi; J F Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

View more
  5 in total

1.  Serum ribonuclease activity in the diagnosis of pancreatic disease.

Authors:  T P Kemmer; P Malfertheiner; M Büchler; M L Kemmer; H Ditschuneit
Journal:  Int J Pancreatol       Date:  1991-01

2.  Secretion of ribonucleases by normal and immortalized cells grown in serum-free culture conditions.

Authors:  M Moenner; E Hatzi; J Badet
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.416

3.  [Changed RNase isoenzyme pattern in ovarian cancers].

Authors:  H Schleich; H Ebert; W Wiest; I Hofmann; J Inthraphuvasak; F Melchert
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

4.  Ovarian carcinoma: increase in clinical validity by simultaneous determination of SRA and CA 125.

Authors:  H G Schleich; W Wiest; R Schmidt; I Hofmann; H P Altenburg; F Melchert
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  A hybrid chimeric system for versatile and ultra-sensitive RNase detection.

Authors:  Stefano Persano; Giuseppe Vecchio; Pier Paolo Pompa
Journal:  Sci Rep       Date:  2015-04-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.